---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-005886"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2023-04-13T23:59:59+00:00"
generated_at: "2026-06-17T02:40:11.644714+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine appoints Elliot Levy, M.D. as independent director

## Summary
- Dr. Levy appointed as class I director; Board size increased by one member effective April 11, 2023.
- He will serve on the Audit Committee and Science and Technology Committee.
- Levy is a Venture Partner at 5AM Ventures; former SVP of R&D at Amgen; boards of Omega Therapeutics and NuCana.
- Annual cash compensation: $40,000 board + $7,500 Audit + $5,000 Science & Tech; option for 50,000 shares vesting over 3 years.
- No arrangement or understanding with any other person pursuant to which he was selected.

## SEC filing metadata
- accession: 0001558370-23-005886
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2023-04-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000155837023005886/0001558370-23-005886-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000155837023005886/edit-20230411x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-005886
- JSON: https://secwatch.observer/filing/0001558370-23-005886.json
- Plain text: https://secwatch.observer/filing/0001558370-23-005886.txt

## Key facts
- Executive change
  Elliot Levy was appointed as Independent Director at Editas Medicine, Inc..
  - Action: appointed
  - Role: Independent Director
  source text: appointed Elliot Levy, M.D. as an independent director, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000155837023005886/0001558370-23-005886-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.